Het Maastricht UMC+ is een academisch ziekenhuis gevestigd in Randwyck in de Nederlandse stad Maastricht. Het ziekenhuis is gelieerd aan de Universiteit Maastricht.

During the past decade, METC Academisch Ziekenhuis Maastricht/Universiteit van Maastricht conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 3 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "METC Academisch Ziekenhuis Maastricht/Universiteit van Maastricht" are "Atrial Fibrillation" (1 trials), "Breast Neoplasms" (1 trials), "Carcinoma, Non-Small-Cell Lung" (1 trials) and "Stroke" (1 trials). Many other conditions were trialed in "METC Academisch Ziekenhuis Maastricht/Universiteit van Maastricht" in a lesser frequency.

Most popular intervention types in "METC Academisch Ziekenhuis Maastricht/Universiteit van Maastricht" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "BIBW 2992" (1 trials), "afatinib" (1 trials), "erlotinib" (1 trials), "trastuzumab" (1 trials) and "vinorelbine" (1 trials). Other intervention names were less common.

The vast majority of trials in "METC Academisch Ziekenhuis Maastricht/Universiteit van Maastricht" are 2 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "METC Academisch Ziekenhuis Maastricht/Universiteit van Maastricht". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in METC Academisch Ziekenhuis Maastricht/Universiteit van Maastricht, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in METC Academisch Ziekenhuis Maastricht/Universiteit van Maastricht, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".